Neuregulin-1 is neuroprotective in a rat model of organophosphate-induced delayed neuronal injury

Toxicology and Applied Pharmacology

Volumn 262, Issue 2, 2012, Pages 194-204

  Li, Yonggang ^a   Lein, Pamela J ^b   Liu, Cuimei ^a   Bruun, Donald A ^b   Giulivi, Cecilia ^b   Ford, Gregory D ^a,c   Tewolde, Teclemichael ^a   Ross Inta, Catherine ^b   Ford, Byron D ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MOREHOUSE COLLEGE   (United States)

Author keywords

Apoptosis; Delayed neurotoxicity; Diisopropylflurophosphate (DFP); Neuroprotection; Organophosphate; Oxidative stress; Rat model

Indexed keywords

ATROPINE METHYL NITRATE; DIISOPROPYLFLUROPHOSPHATE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ORGANOPHOSPHATE; PYRIDOSTIGMINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN REGION; CELL SURVIVAL; CONTROLLED STUDY; MALE; NERVE CELL LESION; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; RAT; SEIZURE;

ANIMALS; ATROPINE; BRAIN; CHOLINESTERASE INHIBITORS; IMMUNOHISTOCHEMISTRY; ISOFLUROPHATE; MALE; NEUREGULIN-1; NEURONS; NEUROPROTECTIVE AGENTS; PROTEIN ISOFORMS; PYRIDOSTIGMINE BROMIDE; RATS; RATS, SPRAGUE-DAWLEY; SEIZURES;

RATTUS;

EID: 84862253891     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2012.05.001     Document Type: Article

References (47)

1. Carlsson T., Schindler F.R., Hollerhage M., Depboylu C., Arias-Carrion O., Schnurrbusch S., Rosler T.W., Wozny W., Schwall G.P., Groebe K., Oertel W.H., Brundin P., Schrattenholz A., Hoglinger G.U. Systemic administration of neuregulin-1beta(1) protects dopaminergic neurons in a mouse model of Parkinson's disease. J. Neurochem. 2011, 117:1066-1074.
2. Collombet J.M., Masqueliez C., Four E., Burckhart M.F., Bernabe D., Baubichon D., Lallement G. Early reduction of NeuN antigenicity induced by soman poisoning in mice can be used to predict delayed neuronal degeneration in the hippocampus. Neurosci. Lett. 2006, 398:337-342.
3. Croslan D.R., Schoell M.C., Ford G.D., Pulliam J.V., Gates A., Clement C.M., Harris A.E., Ford B.D. Neuroprotective effects of neuregulin-1 on B35 neuronal cells following ischemia. Brain Res. 2008, 1210:39-47.
4. De Sarro G., Di Paola E.D., De Sarro A., Vidal M.J. L-arginine potentiates excitatory amino acid-induced seizures elicited in the deep prepiriform cortex. Eur. J. Pharmacol. 1993, 230:151-158.
5. Deshpande L.S., Carter D.S., Blair R.E., DeLorenzo R.J. Development of a prolonged calcium plateau in hippocampal neurons in rats surviving status epilepticus induced by the organophosphate diisopropylfluorophosphate. Toxicol. Sci. 2010, 116:623-631.
6. Ellman G.L., Courtney K.D., Andres V., Feather-Stone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961, 7:88-95.
7. Falls D.L. Neuregulins: functions, forms, and signaling strategies. Exp. Cell Res. 2003, 284:14-30.
8. Fischbach G.D., Rosen K.M. ARIA: a neuromuscular junction neuregulin. Annu. Rev. Neurosci. 1997, 20:429-458.
9. Fujisawa Y., Kato K., Giulivi C. Nitration of tyrosine residues 368 and 345 in the beta-subunit elicits FoF1-ATPase activity loss. Biochem. J. 2009, 423:219-231.
10. Gao R., Zhang J., Cheng L., Wu X., Dong W., Yang X., Li T., Liu X., Xu Y., Li X., Zhou M. A Phase II, randomized, double-blind, multicenter, based on standard therapy, placebo-controlled study of the efficacy and safety of recombinant human neuregulin-1 in patients with chronic heart failure. J. Am. Coll. Cardiol. 2010, 55:1907-1914.
11. Golomb B.A. Acetylcholinesterase inhibitors and Gulf War illnesses. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:4295-4300.
12. Guo W.P., Wang J., Li R.X., Peng Y.W. Neuroprotective effects of neuregulin-1 in rat models of focal cerebral ischemia. Brain Res. 2006, 1087:180-185.
13. Gupta R.C., Milatovic D., Dettbarn W.D. Nitric oxide modulates high-energy phosphates in brain regions of rats intoxicated with diisopropylphosphorofluoridate or carbofuran: prevention by N-tert-butyl-alpha-phenylnitrone or vitamin E. Arch. Toxicol. 2001, 75:346-356.
14. Haynes V., Traaseth N.J., Elfering S., Fujisawa Y., Giulivi C. Nitration of specific tyrosines in FoF1 ATP synthase and activity loss in aging. Am. J. Physiol. Endocrinol. Metab. 2010, 298:E978-E987.
15. Hoffman A., Eisenkraft A., Finkelstein A., Schein O., Rotman E., Dushnitsky T. A decade after the Tokyo sarin attack: a review of neurological follow-up of the victims. Mil. Med. 2007, 172:607-610.
16. Holmes W.E., Sliwkowski M.X., Akita R.W., Henzel W.J., Lee J., Park J.W., Yansura D., Abadi N., Raab H., Lewis G.D., et al. Identification of heregulin, a specific activator of p185erbB2. Science 1992, 256:1205-1210.
17. Iaci J.F., Ganguly A., Finklestein S.P., Parry T.J., Ren J., Saha S., Sietsma D.K., Srinivas M., Vecchione A.M., Caggiano A.O. Glial growth factor 2 promotes functional recovery with treatment initiated up to 7days after permanent focal ischemic stroke. Neuropharmacology 2010, 59:640-649.
18. Jabbour A., Hayward C.S., Keogh A.M., Kotlyar E., McCrohon J.A., England J.F., Amor R., Liu X., Li X.Y., Zhou M.D., Graham R.M., Macdonald P.S. Parenteral administration of recombinant human neuregulin-1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses. Eur. J. Heart Fail. 2011, 13:83-92.
19. Jett D.A. Neurological aspects of chemical terrorism. Ann. Neurol. 2007, 61:9-13.
20. Kadriu B., Guidotti A., Costa E., Auta J. Imidazenil, a non-sedating anticonvulsant benzodiazepine, is more potent than diazepam in protecting against DFP-induced seizures and neuronal damage. Toxicology 2009, 256:164-174.
21. Kastin A.J., Akerstrom V., Pan W. Neuregulin-1-beta1 enters brain and spinal cord by receptor-mediated transport. J. Neurochem. 2004, 88:965-970.
22. Kato T., Abe Y., Sotoyama H., Kakita A., Kominami R., Hirokawa S., Ozaki M., Takahashi H., Nawa H. Transient exposure of neonatal mice to neuregulin-1 results in hyperdopaminergic states in adulthood: implication in neurodevelopmental hypothesis for schizophrenia. Mol. Psychiatry 2011, 16:307-320.
23. Kim Y.-B., Hur G., Shin S., Sok D., Kang J., Lee Y. Organophosphate-induced brain injuries: delayed apoptosis mediated by nitric oxide. Environ. Toxicol. Pharmacol. 1999, 7:147-152.
24. Lemercier G., Carpentier P., Sentenac-Roumanou H., Morelis P. Histological and histochemical changes in the central nervous system of the rat poisoned by an irreversible anticholinesterase organophosphorus compound. Acta Neuropathol. (Berl) 1983, 61:123-129.
25. Li B.S., Ma W., Jaffe H., Zheng Y., Takahashi S., Zhang L., Kulkarni A.B., Pant H.C. Cdk5 is involved in neuregulin-dependent activation of PI-3 kinase and Akt activity mediating neuronal survival. J. Biol. Chem. 2003, 278:35702-35709.
26. Li Y., Xu Z., Ford G.D., Croslan D.R., Cairobe T., Li Z., Ford B.D. Neuroprotection by neuregulin-1 in a rat model of permanent focal cerebral ischemia. Brain Res. 2007, 1184:277-283.
27. Li Q., Zhang R., Guo Y.L., Mei Y.W. Effect of neuregulin on apoptosis and expressions of STAT3 and GFAP in rats following cerebral ischemic reperfusion. J. Mol. Neurosci. 2009, 37:67-73.
28. Li Y., Lein P.J., Liu C., Bruun D.A., Tewolde T., Ford G., Ford B.D. Spatiotemporal pattern of neuronal injury induced by DFP in rats: a model for delayed neuronal cell death following acute OP intoxication. Toxicol. Appl. Pharmacol. 2011, 253:261-269.
29. Loeb J.A., Fischbach G.D. ARIA can be released from extracellular matrix through cleavage of a heparin-binding domain. J. Cell Biol. 1995, 130:127-135.
30. McDonough J.H., McLeod C.G., Nipwoda M.T. Direct microinjection of soman or VX into the amygdala produces repetitive limbic convulsions and neuropathology. Brain Res. 1987, 435:123-137.
31. McLeod C.G., Singer A.W., Harrington D.G. Acute neuropathology in soman poisoned rats. Neurotoxicology 1984, 5:53-57.
32. Newmark J. The birth of nerve agent warfare: lessons from Syed Abbas Foroutan. Neurology 2004, 62:1590-1596.
33. Okudera H. Clinical features on nerve gas terrorism in Matsumoto. J. Clin. Neurosci. 2002, 9:17-21.
34. Okumura T., Hisaoka T., Yamada A., Naito T., Isonuma H., Okumura S., Miura K., Sakurada M., Maekawa H., Ishimatsu S., Takasu N., Suzuki K. The Tokyo subway sarin attack-lessons learned. Toxicol. Appl. Pharmacol. 2005, 207:471-476.
35. Petras J.M. Neurology and neuropathology of Soman-induced brain injury: an overview. J. Exp. Anal. Behav. 1994, 61:319-329.
36. Rosler T.W., Depboylu C., Arias-Carrion O., Wozny W., Carlsson T., Hollerhage M., Oertel W.H., Schrattenholz A., Hoglinger G.U. Biodistribution and brain permeability of the extracellular domain of neuregulin-1-beta1. Neuropharmacology 2011, 61:1413-1418.
37. Ross-Inta C., Omanska-Klusek A., Wong S., Barrow C., Garcia-Arocena D., Iwahashi C., Berry-Kravis E., Hagerman R.J., Hagerman P.J., Giulivi C. Evidence of mitochondrial dysfunction in fragile X-associated tremor/ataxia syndrome. Biochem. J. 2010, 429:545-552.
38. Sato M., Chang E., Igarashi T., Noble L.J. Neuronal injury and loss after traumatic brain injury: time course and regional variability. Brain Res. 2001, 917:45-54.
39. Shih T., Whalley C.E., Valdes J.J. A comparison of cholinergic effects of HI-6 and pralidoxime-2-chloride (2-PAM) in soman poisoning. Toxicol. Lett. 1991, 55:131-147.
40. Shyu W.C., Lin S.Z., Chiang M.F., Yang H.I., Thajeb P., Li H. Neuregulin-1 reduces ischemia-induced brain damage in rats. Neurobiol. Aging 2004, 25:935-944.
41. Soltaninejad K., Abdollahi M. Current opinion on the science of organophosphate pesticides and toxic stress: a systematic review. Med. Sci. Monit. 2009, 15:RA75-RA90.
42. Talmage D.A., Role L.W. Multiple personalities of neuregulin gene family members. J. Comp. Neurol. 2004, 472:134-139.
43. Unal-Cevik I., Kilinc M., Gursoy-Ozdemir Y., Gurer G., Dalkara T. Loss of NeuN immunoreactivity after cerebral ischemia does not indicate neuronal cell loss: a cautionary note. Brain Res. 2004, 1015:169-174.
44. Xu Z., Jiang J., Ford G., Ford B.D. Neuregulin-1 is neuroprotective and attenuates inflammatory responses induced by ischemic stroke. Biochem. Biophys. Res. Commun. 2004, 322:440-446.
45. Xu Z., Ford G.D., Croslan D.R., Jiang J., Gates A., Allen R., Ford B.D. Neuroprotection by neuregulin-1 following focal stroke is associated with the attenuation of ischemia-induced pro-inflammatory and stress gene expression. Neurobiol. Dis. 2005, 19:461-470.
46. Xu Z., Croslan D.R., Harris A.E., Ford G.D., Ford B.D. Extended therapeutic window and functional recovery after intraarterial administration of neuregulin-1 after focal ischemic stroke. J. Cereb. Blood Flow Metab. 2006, 26:527-535.
47. Yanagisawa N., Morita H., Nakajima T. Sarin experiences in Japan: acute toxicity and long-term effects. J. Neurol. Sci. 2006, 249:76-85.